Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy

Ségolène Galandrin and Michel Bouvier
Molecular Pharmacology November 2006, 70 (5) 1575-1584; DOI: https://doi.org/10.1124/mol.106.026716
Ségolène Galandrin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Bouvier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 70 no. 5 1575-1584
DOI 
https://doi.org/10.1124/mol.106.026716
PubMed 
16901982

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 15, 2006
  • Accepted August 10, 2006
  • Published online October 20, 2006.

Article Versions

  • Earlier version (August 10, 2006 - 08:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ségolène Galandrin and
  2. Michel Bouvier
  1. Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada
  1. Address correspondence to:
    Dr. Michel Bouvier, Department of Biochemistry, Groupe de Recherche Universitaire sur le Médicament and Institute for Research in Immunology and Cancer, Université de Montréal, C.P. 6128 Succursale Centre-Ville, Montréal, QC, Canada, H3C 3J7. E-mail: michel. bouvier{at}umontreal.ca
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2006 to February 2023

AbstractFullPdf
Aug 2006640222
Sep 2006170108
Oct 200616553253
Nov 2006426088
Dec 2006223748
Jan 2007387676
Feb 2007157362
Mar 2007183747
Apr 2007143334
May 2007184967
Jun 2007203326
Jul 200783234
Aug 2007163528
Sep 2007182636
Oct 2007266064
Nov 2007196371
Dec 2007113635
Jan 2008164338
Feb 2008105341
Mar 2008235047
Apr 2008213530
May 2008172821
Jun 200895237
Jul 2008236735
Aug 2008344522
Sep 2008315736
Oct 2008154536
Nov 2008307253
Dec 200882614
Jan 2009203119
Feb 2009122423
Mar 2009524325
Apr 2009253825
May 2009222528
Jun 2009182225
Jul 2009253522
Aug 2009233732
Sep 2009262331
Oct 2009313837
Nov 2009283143
Dec 2009332736
Jan 2010523126
Feb 2010393724
Mar 2010293931
Apr 2010244621
May 2010182010
Jun 2010183525
Jul 2010133521
Aug 2010363119
Sep 2010152014
Oct 2010152015
Nov 2010143816
Dec 2010142119
Jan 2011142420
Feb 2011172612
Mar 2011183724
Apr 2011162721
May 2011143436
Jun 2011132013
Jul 2011172621
Aug 2011242120
Sep 2011192820
Oct 2011264027
Nov 2011325329
Dec 2011222516
Jan 2012193227
Feb 2012123224
Mar 201293522
Apr 2012143026
May 2012242212
Jun 2012221211
Jul 2012283217
Aug 2012172616
Sep 2012202920
Oct 2012143025
Nov 2012285066
Dec 2012372823
Jan 2013515738
Feb 2013293623
Mar 2013444628
Apr 2013443733
May 2013273840
Jun 2013131523
Jul 2013111423
Aug 201362415
Sep 2013193420
Oct 2013153220
Nov 2013122311
Dec 2013132914
Jan 2014255236
Feb 2014233319
Mar 2014234238
Apr 2014194117
May 2014223737
Jun 2014273623
Jul 201416208
Aug 2014142112
Sep 2014214120
Oct 2014509831
Nov 2014344524
Dec 2014162016
Jan 2015282717
Feb 201517189
Mar 2015344018
Apr 2015172712
May 2015201911
Jun 2015153115
Jul 2015262116
Aug 20158184
Sep 2015203819
Oct 2015172118
Nov 2015201315
Dec 2015162012
Jan 2016352413
Feb 2016582632
Mar 2016252718
Apr 2016181918
May 2016172317
Jun 2016131810
Jul 2016132212
Aug 2016172915
Sep 2016131811
Oct 20167219
Nov 201664312
Dec 20164167
Jan 201744211
Feb 20170235
Mar 201784518
Apr 20174209
May 2017103324
Jun 20172232
Jul 20170161
Aug 201773521
Sep 201723117
Oct 201725121
Nov 2017101526
Dec 2017435519
Jan 201832768
Feb 2018819420
Mar 2018313516
Apr 2018011815
May 2018110915
Jun 201807319
Jul 201805221
Aug 201817418
Sep 201807221
Oct 201806524
Nov 201809228
Dec 2018572316
Jan 201968517
Feb 20196009
Mar 201928810
Apr 20192146
May 2019191412
Jun 201914824
Jul 2019451430
Aug 2019391013
Sep 2019321415
Oct 2019322430
Nov 2019452014
Dec 2019381211
Jan 20201391
Feb 20201881
Mar 202026188
Apr 20203483
May 202018158
Jun 20201153
Jul 20201792
Aug 20201894
Sep 202033146
Oct 202038149
Nov 202030710
Dec 202031158
Jan 202161359
Feb 202130396
Mar 20213395
Apr 20212576
May 202121206
Jun 202111202
Jul 202120611
Aug 202122212
Sep 202144231
Oct 202127103
Nov 202137127
Dec 20212171
Jan 20224055
Feb 20222373
Mar 202235138
Apr 20224274
May 20222373
Jun 20222444
Jul 20221422
Aug 202227108
Sep 202237265
Oct 202231193
Nov 2022461710
Dec 202231115
Jan 202321114
Feb 2023711

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 70 (5)
Molecular Pharmacology
Vol. 70, Issue 5
1 Nov 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy

Ségolène Galandrin and Michel Bouvier
Molecular Pharmacology November 1, 2006, 70 (5) 1575-1584; DOI: https://doi.org/10.1124/mol.106.026716

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy

Ségolène Galandrin and Michel Bouvier
Molecular Pharmacology November 1, 2006, 70 (5) 1575-1584; DOI: https://doi.org/10.1124/mol.106.026716
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics